Search research articles
Contact Us
Filters
Showing results (101-110 of 124) with videos related to
Page
of 13
Sort By:
BMC Cancer
|
February 13, 2019
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials
Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
[<sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study
David L Chan, Aimee Hayes, Ioannis Karfis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Preoperative Assessment of Peritoneal Carcinomatosis with [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [<sup>18</sup>F]FDG PET/CT
Ayça Arçay Öztürk, Gabriel Liberale, Anne-Leen Deleu, et al.
NPJ Breast Cancer
|
September 22, 2021
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
Andrea Gombos, David Venet, Lieveke Ameye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
Alain Hendlisz, Marc Van den Eynde, Marc Peeters, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2024
[<sup>18</sup>F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
David L Chan, Aimee R Hayes, Ioannis Karfis, et al.
BMC Cancer
|
April 17, 2013
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Alain Hendlisz, Vassilis Golfinopoulos, Amelie Deleporte, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2026
<sup>211</sup>At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges
Hugo Levillain, Anne Royer Moës, Cristiana Gameiro-Paris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick, Theo Ruers, Daniela E Aust, et al.
Cancers
|
September 29, 2020
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial <sup>18</sup>F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
Silvia Camera, Tugba Akin Telli, Erwin Woff, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 124) with videos related to
Sort By:
Page
of 13
BMC Cancer
|
February 13, 2019
Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials
Nicolas Charette, Caroline Vandeputte, Lieveke Ameye, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 22, 2025
[<sup>18</sup>F]FDG Metabolic Tumor Volume as a Prognostic Marker in Neuroendocrine Neoplasm: A Multicenter Study
David L Chan, Aimee Hayes, Ioannis Karfis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 21, 2026
Preoperative Assessment of Peritoneal Carcinomatosis with [<sup>68</sup>Ga]Ga-FAPI-46 PET/CT: Agreement with Surgicopathologic PCI and Comparison with MRI and [<sup>18</sup>F]FDG PET/CT
Ayça Arçay Öztürk, Gabriel Liberale, Anne-Leen Deleu, et al.
NPJ Breast Cancer
|
September 22, 2021
FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer
Andrea Gombos, David Venet, Lieveke Ameye, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 23, 2010
Phase III trial comparing protracted intravenous fluorouracil infusion alone or with yttrium-90 resin microspheres radioembolization for liver-limited metastatic colorectal cancer refractory to standard chemotherapy
Alain Hendlisz, Marc Van den Eynde, Marc Peeters, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 2, 2024
[<sup>18</sup>F]FDG PET/CT-Avid Discordant Volume as a Biomarker in Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Multicenter Study
David L Chan, Aimee R Hayes, Ioannis Karfis, et al.
BMC Cancer
|
April 17, 2013
Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study
Alain Hendlisz, Vassilis Golfinopoulos, Amelie Deleporte, et al.
European Journal of Nuclear Medicine and Molecular Imaging
|
May 28, 2026
<sup>211</sup>At targeted alpha therapy in Europe: overcoming clinical, regulatory, and infrastructure challenges
Hugo Levillain, Anne Royer Moës, Cristiana Gameiro-Paris, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 22, 2008
European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer
Florian Lordick, Theo Ruers, Daniela E Aust, et al.
Cancers
|
September 29, 2020
Prognostic Value of the Pace of Tumor Progression as Assessed by Serial <sup>18</sup>F-FDG PET/CT Scan and Liquid Biopsy in Refractory Colorectal Cancer: The CORIOLAN Trial
Silvia Camera, Tugba Akin Telli, Erwin Woff, et al.
Page
of 13